UB Paderborn / Katalog / Suche / in CDI

Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis

Scientific reports, 2022-05, Vol.12 (1), p.7498-7498, Article 7498

2022

Link zum Volltext

Verfügbarkeit prüfen

Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study

PloS one, 2018-10, Vol.13 (10), p.e0205506-e0205506

2018

Link zum Volltext

Verfügbarkeit prüfen

Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study

Rheumatology international, 2020-06, Vol.40 (6), p.951-958

2020

Link zum Volltext

Verfügbarkeit prüfen

Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting

Clinical rheumatology, 2020-09, Vol.39 (9), p.2663-2670

2020

Link zum Volltext

Verfügbarkeit prüfen

The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational “real-life” study

Scientific reports, 2023-11, Vol.13 (1), p.20146-20146, Article 20146

2023

Link zum Volltext

Verfügbarkeit prüfen

Performance and calibration of the algorithm ASSIGN in predicting cardiovascular disease in Italian patients with psoriatic arthritis

Clinical rheumatology, 2019-04, Vol.38 (4), p.971-976

2019

Link zum Volltext

Verfügbarkeit prüfen

Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis

Journal of clinical medicine, 2023-03, Vol.12 (7), p.2586

2023

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment

Rheumatology and therapy., 2020-12, Vol.7 (4), p.867-882

2020

Link zum Volltext

Verfügbarkeit prüfen

Necrobiosis-Lipoidica-Like Skin Lesions in a Patient with Non-Systemic Sarcoidosis

Dermatology practical & conceptual, 2023-07, Vol.13 (3), p.e2023183

2023

Link zum Volltext

Verfügbarkeit prüfen

2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus

Biomedicines, 2022-07, Vol.10 (7), p.1675

2022

Link zum Volltext

Verfügbarkeit prüfen

A machine-learning approach to cardiovascular risk prediction in psoriatic arthritis

Rheumatology (Oxford, England), 2020-07, Vol.59 (7), p.1767-1769

2020

Link zum Volltext

Verfügbarkeit prüfen

Secukinumab‐induced subacute cutaneous lupus erythematosus

Dermatologic therapy, 2020-05, Vol.33 (3), p.e13417-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients

Journal of autoimmunity, 2020-09, Vol.113, p.102470-102470, Article 102470

2020

Link zum Volltext

Verfügbarkeit prüfen

Moderate‐to‐severe plaque psoriasis, described by PASI ≥10%, can be associated with higher cardiovascular risk according to seven risk algorithms: Results of a 10‐year single‐center retrospective study and clinical management of psoriatic patients with cardiovascular risk

Dermatologic therapy, 2020-11, Vol.33 (6), p.e14451-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus

Autoimmunity reviews, 2024-07, p.103581, Article 103581

2024

Link zum Volltext

Verfügbarkeit prüfen

Experimental and Investigational Pharmacotherapy for Psoriatic Arthritis: Drugs of the Future

Journal of experimental pharmacology, 2020-11, Vol.12, p.487-502

2020

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis

Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study

Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study

Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting

The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational “real-life” study

Performance and calibration of the algorithm ASSIGN in predicting cardiovascular disease in Italian patients with psoriatic arthritis

The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles

Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis

Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment

Necrobiosis-Lipoidica-Like Skin Lesions in a Patient with Non-Systemic Sarcoidosis

Increased Prevalence of Headaches and Migraine in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: Insights from an Italian Cohort Study

2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus

A machine-learning approach to cardiovascular risk prediction in psoriatic arthritis

Secukinumab‐induced subacute cutaneous lupus erythematosus

Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients

The similar expression of both ferritin and scavenger receptors activation genes in patients with COVID19 and AOSD support their role in the pathogenesis of these diseases and identify a common mechanism at the basis of the “hyperferritinemic syndromes”

Moderate‐to‐severe plaque psoriasis, described by PASI ≥10%, can be associated with higher cardiovascular risk according to seven risk algorithms: Results of a 10‐year single‐center retrospective study and clinical management of psoriatic patients with cardiovascular risk

Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus

Experimental and Investigational Pharmacotherapy for Psoriatic Arthritis: Drugs of the Future

Suchergebnisse filtern